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Abstract
Metastases to the breast are unusual lesions that make up approximately 2% of all malignant
mammary neoplasms and may mimic both benign and malignant primary neoplasms from a clinical
point of view, as well as in imaging studies. Arriving at a correct diagnosis is therefore essential in
order to establish appropriate management.
We present three cases of metastatic neoplasms diagnosed through fine needle aspiration biopsy
and immunocytochemistry. The cytological diagnoses were: medulloblastoma in an 18-year-old
woman, melanoma in a 26-year-old man, and an exceptional case of ovarian sarcoma originating
from a granulosa cell tumor with metastases to both breasts. A metastatic disease should be
considered in the differential diagnosis of a palpable mass in the breast, especially if there is a history
of an extramammary malignant neoplasm. Fine needle aspiration biopsy is the method of choice for
the management of these cases.
Whenever possible the exam of the material obtained should be compared to the previous biopsy,
which is usually enough to arrive at a correct diagnosis, thus preventing unnecessary surgical
procedures.
Introduction
Metastatic neoplasms of the breast are very rare [1,2]. They
may mimic benign and malignant primary neoplasms
both clinically and radiologically [3], and the clinical
diagnosis often goes unsuspected, especially when the
first manifestation of the clinical picture is a breast tumor
and the existence of a primary neoplasm is unknown or
not taken into consideration [4]. In most cases, manage-
ment through fine needle aspiration biopsy (FNAB) per-
mits the correct diagnosis of a metastatic neoplasm, which
prevents unnecessary radical surgeries and allows us to
start appropriate systemic treatment promptly [5].
For FNAB evaluation it is necessary to know the patient's
clinical history. It will usually be easier to achieve a defin-
itive diagnosis when the history of extramammary
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malignant neoplasm is known. Therefore, metastatic
lesions should be considered in the differential diagnosis
of tumors of the breast, particularly in those cases present-
ing unusual clinical, radiological, or cytological character-
istics. For the latter, it is very useful to perform
immunocytochemistry stains on the smears or cell blocks
to arrive at a definitive diagnosis.
Materials and methods
Three cases of metastatic neoplasms of the breast were
identified through FNAB, from a total 639 aspirates of
breast tumors performed between January 2001 and
December 2003 at the Aspiration Room of the Anatomical
Pathology and Cytopathology Service of the Hospital Uni-
versitario. The pathologist performed all the procedures
by using a gauge 22 needle in a 10 ml syringe. One or two
punctures were performed in each case, with an average of
four smears per patient. An air-dried smear was stained
with Diff-Quik for immediate evaluation of the sample,
and the rest were fixed with 95° alcohol and stained by
Papanicolau's method. Additionally, immunohistochem-
istry stains were performed on the cytological material
[Table 1].
Results
Out of a total 639 aspiration biopsies of the breast, 3 cases
(0.4%) were diagnosed as metastatic neoplasms. In the
three cases, immunochemistry was performed on the
smears to corroborate the diagnosis, and the histological
slides of the primary tumor were reviewed in order to
compare them with the original morphology.
Case description
Case 1
An 18-year-old female patient with a history of cerebellar
medulloblastoma diagnosed 18 months before admis-
sion. At the time she was treated with subtotal surgical
resection and the placement of a ventricular peritoneal
shunt, in addition to radiotherapy. This time she pre-
sented with a tumor of the right breast and bone pain.
The physical examination revealed a lobulated tumor of
the breast, approximately 3 cm in diameter, with poorly
defined margins, no changes in the overlying skin and no
axillary or supraclavicular adenopathies. An FNAB proce-
dure was performed on the tumor, which yielded abun-
dant material consisting of a population of non-cohesive,
small, round cells with scant cytoplasm and a high
nucleus-cytoplasm ratio. The nuclei were rounded and
some of them were elongated, with lumpy chromatin and
small nucleoli.
Immunocytochemistry was performed, which was posi-
tive for neuron-specific enolase and negative for the com-
mon leukocyte antigen. The cytological diagnosis was
metastatic medulloblastoma. Fig. 1
Case 2
A 26-year-old man with a history of being diagnosed with
a skin melanoma three years earlier, he presents with a
firm, poorly-defined, multinodular retroareolar mass,
approximately 5 cm in diameter. The smears showed
numerous cells, predominantly epithelioid-looking,
forming slightly cohesive groups, as well as isolated polyg-
onal cells with cytoplasmic elongations and nuclei with
acidophilic macronucleoli and pseudoinclusions. Scant
cells with melanotic pigment were identified.
Immunohistochemistry was performed, with the follow-
ing results: negative for cytokeratin, positive for vimentin,
S-100 protein, and HMB45. A metastatic melanoma was
diagnosed. Fig. 2
Case 3
A 55-year-old woman who was diagnosed with a granu-
losa cell tumor of the ovary with sarcomatous differentia-
tion a year prior to her admission, at present she shows
several fastgrowing nodular tumors in both breasts, as
well as imaging suggesting metastasis to the liver. FNAB of
both breasts was performed.
The smears showed numerous neoplastic cells, predomi-
nantly spindle-shaped cells forming small groups, inter-
Table 1: Immunochemical markers used:
Antibody Company Dilution HIER
CD 45 DAKO 1:100 yes
ENE DAKO 1:200 no
S-100 Protein DAKO 1:200 yes
HMB 45 DAKO 1:50 yes
Vimentin DAKO 1:200 yes
Cytokeratin AE1 DAKO 1:200 yes
CA 15-3 DAKO 1:250 yes
HIER: Heat induce epitope retrievalCytoJournal 2005, 2:17 http://www.cytojournal.com/content/2/1/17
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mingled with other pleomorphic and isolated polygonal
cells with large nuclei and no nucleoli. Immunohisto-
chemistry was negative for cytokeratin and CA 15-3, and
positive for vimentin. A metastatic sarcoma was diag-
nosed. Fig 3.
Discussion
Metastases to the breast of neoplasms originating in
organs other than the breast are very rare. In a series of
2529 breast aspiration biopsies, 666 were diagnosed as
malignant neoplasms, and only 18 (2.7%) were of
extramammary origin [5]. The identification of a second-
ary neoplasm in the breast is clinically complicated
because secondary neoplasms appear as well-circum-
scribed rounded masses, most often located in the upper
outer quadrant, and without the spiculations or microcal-
cifications of primary carcinomas [6]. On the other hand,
the presence of well-circumscribed multiple or bilateral
nodules may suggest a benign process in the mammogra-
phy [7].
Since metastatic neoplasms may mimic primary tumors, it
is important to know the patient's clinical history when
interpreting the FNAB. However, for patients with
unknown primary neoplasms the metastatic nature of the
lesion should be suspected when we find unusual cytolog-
ical patterns. Immunocytochemistry techniques are
undoubtedly of great use in the latter cases.
Some clinical characteristics help us identify neoplasms of
the breast that have a metastatic origin: the time span for
the development of metastasis in patients with previously
treated cancers is approximately two years. Metastases are
usually to other sites or are detected simultaneously; by
contrast, isolated metastases limited to the breast are
infrequent [8].
a y b: Papamicolaou; c: biopsy; d: CD45; e: neuron specific enolase; f: vimentin Figure 1
a y b: Papamicolaou; c: biopsy; d: CD45; e: neuron specific enolase; f: vimentin.CytoJournal 2005, 2:17 http://www.cytojournal.com/content/2/1/17
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a, b, c: Papanicolaou; d: HMB-45; e: skin biopsy; f, g, h: breast tumor Figure 2
a, b, c: Papanicolaou; d: HMB-45; e: skin biopsy; f, g, h: breast tumor.
a: Papanicolaou; b: cytokeratin; c: CA 15-3; d: vimentin; e, f: ovarian tumor; g: inhibin; h: WT1 Figure 3
a: Papanicolaou; b: cytokeratin; c: CA 15-3; d: vimentin; e, f: ovarian tumor; g: inhibin; h: WT1.Publish with BioMed Central    and   every 
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Although virtually any malignant neoplasm can metasta-
size to the breast, this is most common for melanomas,
carcinomas of the lung, neuroendrocrine and carcinoid
carcinomas, ovarian carcinomas, and lymphoid and
hematopoietic neoplasms [5,8-11]. Extracranial
metastases of medulloblastoma occur in 5% to 7% of
cases, and they are mainly related to ventricular peritoneal
shunts. Most frequently affected sites are the bones, the
lymphatic nodes, the liver, and the lungs, with isolated
cases reported for other organs, such as the breast, for
which only five cases have been described in the literature.
Three of these cases were diagnosed through fine needle
aspiration biopsy [12-16].
The cytological differential diagnosis includes lobular car-
cinoma, small-cell carcinoma, carcinoid tumor, lym-
phoma, and leukemic infiltration. Melanomas are some
of the neoplasms that most often metastasize to the
breast. Such metastases may be hard to recognize if the
primary tumor is hiding or if there is no history of this
tumor [17,18].
In addition, there is only one reported case of granulosa
cell ovarian tumor metastatic to the breast diagnosed
through a biopsy [19], and there are no previous reports
of cases diagnosed with FNAB.
Conclusion
Metastatic disease should be taken into consideration in
the differential diagnosis of a tumor of the breast, espe-
cially if there is a history of an extramammary malignant
neoplasm. FNAB, in combination with Immunohisto-
chemistry, is the method of choice for the initial manage-
ment of these cases. On the other hand, comparing the
cytological findings with the previous biopsy will be usu-
ally enough to arrive at a correct diagnosis, thus prevent-
ing unnecessary radical surgical procedures and allowing
us to establish the treatment of choice promptly and
safely.
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